Shot chasers: big pharma’s covid-19 boost

episode

Economist Podcasts not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Economist Podcasts

National front-runner: who can beat Le Pen? 19 min · 23 Sep 2026

The mob rule: criminality consumes South Africa 20 min · 22 Sep 2026

Centre punch: Germany’s state-election shocker 21 min · 21 Sep 2026

Drone truth: Russia has the upper hand 25 min · 18 Sep 2026

Rise and shine: Warsh’s Fed rate test 23 min · 17 Sep 2026

The end of the world is AI? An existential threat 24 min · 16 Sep 2026

All episodes from Economist Podcasts →

Report any issue

Source

Recorded26 May 2020

Publisherrss.acast.com ↗

Handlerec:472439

Show notes

The pandemic has caused a shift in how drug firms are viewed: their capacity for big-money innovation will give them immunity in the crisis. Widespread homeworking will have broad consequences, from commercial-property values to urban demographics. And a seemingly innocuous Hong Kong history exam is a window into the territory’s increasingly fraught politics. For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/radiooffer Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in